Bangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...
Biocon said that it's wholly owned subsidiary, Biocon Pharma, has received approval for Tacrolimus capsule in 0.5mg, 1mg and 5mg strengths, from the National Medical Products Administration (NMPA), ...
The FDA receives reports from food companies almost daily regarding potential allergens or foodborne illnesses. Here's a look ...
Tacrolimus, an immunosuppressant, is used to reduce organ rejection in transplant patients by suppressing the immune system. This approval broadens Biocon’s portfolio of complicated medicinal ...
More recent studies have shown that pets inside the home protect children from allergies, and the protection increases with ...
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) recently completed the second closing of its offering on December 31, 2024, as detailed in an 8-K filing with the United States Securities and Exchange ...
Statins, often used to treat high cholesterol levels and prevent heart attacks and strokes, can also be affected by ...
Astellas Pharma and Endo subsidiary Endo USA issued voluntary recalls for products they manufacture over concerns of empty tablets and unapproved ingredients, respectively. | Astellas Pharma and Endo ...
Hero MotoCorp: Hero MotoCorp, India’s top two-wheeler manufacturer, recorded a 7.5% increase in total sales to 59,11,065 ...
Background: Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback